Taysha Gene Therapies, Inc.

TSHA · XNAS

CIK 1806310fmd_1RJCBQZ0DND92J7J7G3TCGWS8MManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods

Ratios computed from the standardized statements. Select a value to open its proof.